BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2396864)

  • 1. Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.
    Månsson B; Geborek P; Saxne T; Björnsson S
    Ann Rheum Dis; 1990 Aug; 49(8):594-7. PubMed ID: 2396864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis.
    Thompson PW; Jones DD; Currey HL
    Ann Rheum Dis; 1986 Jan; 45(1):9-14. PubMed ID: 3954467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytidine deaminase and lactoferrin in inflammatory synovial fluids. Indicators of local polymorphonuclear cell function?
    Geborek P; Månsson B; Hellmer G; Saxne T
    Br J Rheumatol; 1992 Apr; 31(4):235-40. PubMed ID: 1555038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
    Yuksel H; Akoğlu TF
    Ann Rheum Dis; 1988 Jun; 47(6):492-5. PubMed ID: 3382270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints.
    Geborek P; Saxne T; Pettersson H; Wollheim FA
    J Rheumatol; 1989 Apr; 16(4):468-72. PubMed ID: 2746586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis.
    Caccavo D; Sebastiani GD; Di Monaco C; Guido F; Galeazzi M; Ferri GM; Bonomo L; Afeltra A
    Int J Clin Lab Res; 1999; 29(1):30-5. PubMed ID: 10356661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
    Saxne T; Heinegård D; Wollheim FA; Pettersson H
    Lancet; 1985 Jul; 2(8447):127-8. PubMed ID: 2862321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis.
    Moore AR; Appelboam A; Kawabata K; Da Silva JA; D'Cruz D; Gowland G; Willoughby DA
    Ann Rheum Dis; 1999 Feb; 58(2):109-13. PubMed ID: 10343526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial fluid ferritin, lactoferrin and adenosine deaminase in rheumatic diseases.
    Klockars M; Pettersson T; Vilja P; von Essen R
    Br J Rheumatol; 1990 Aug; 29(4):318-9. PubMed ID: 2379056
    [No Abstract]   [Full Text] [Related]  

  • 10. Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.
    Saxne T; Heinegård D; Wollheim FA
    Arthritis Rheum; 1987 Sep; 30(9):972-9. PubMed ID: 3663262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
    Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
    Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
    Saxne T; Wollheim FA; Pettersson H; Heinegård D
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1447-8. PubMed ID: 3121058
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.
    Saxne T; Heinegård D; Wollheim FA
    Ann Rheum Dis; 1986 Jun; 45(6):491-7. PubMed ID: 3729574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase activity in joint effusions.
    Pettersson T; Klockars M; Weber TH; von Essen R
    Scand J Rheumatol; 1988; 17(5):365-9. PubMed ID: 3212407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage.
    Saxne T; Heinegård D; Wollheim FA
    Coll Relat Res; 1988 May; 8(3):233-47. PubMed ID: 3396307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cytidine deaminase levels after withdrawal of non-steroidal anti-inflammatory treatment in rheumatoid arthritis.
    Thompson PW; Kirwan JR; Jones DD; Currey HL
    Ann Rheum Dis; 1988 Apr; 47(4):308-12. PubMed ID: 3365029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythm of serum cytidine deaminase in patients with rheumatoid arthritis during rest and exercise.
    Thompson PW; James IT; Wheatcroft S; Pownall R; Barnes CG
    Ann Rheum Dis; 1989 Jun; 48(6):502-4. PubMed ID: 2742404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T; Lecander I; Geborek P
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.
    Hørslev-Petersen K; Saxne T; Haar D; Thomsen BS; Bentsen KD; Junker P; Lorenzen I
    Rheumatol Int; 1988; 8(1):1-9. PubMed ID: 3259005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine catabolic enzymes in human synovial fluids.
    Wortmann RL; Veum JA; Rachow JW
    Adv Exp Med Biol; 1989; 253A():393-8. PubMed ID: 2560334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.